Literature DB >> 21195251

Borderline personality disorder.

Falk Leichsenring1, Eric Leibing, Johannes Kruse, Antonia S New, Frank Leweke.   

Abstract

Recent research findings have contributed to an improved understanding and treatment of borderline personality disorder. This disorder is characterised by severe functional impairments, a high risk of suicide, a negative effect on the course of depressive disorders, extensive use of treatment, and high costs to society. The course of this disorder is less stable than expected for personality disorders. The causes are not yet clear, but genetic factors and adverse life events seem to interact to lead to the disorder. Neurobiological research suggests that abnormalities in the frontolimbic networks are associated with many of the symptoms. Data for the effectiveness of pharmacotherapy vary and evidence is not yet robust. Specific forms of psychotherapy seem to be beneficial for at least some of the problems frequently reported in patients with borderline personality disorder. At present, there is no evidence to suggest that one specific form of psychotherapy is more effective than another. Further research is needed on the diagnosis, neurobiology, and treatment of borderline personality disorder. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21195251     DOI: 10.1016/S0140-6736(10)61422-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  172 in total

Review 1.  Suicidal risk and management in borderline personality disorder.

Authors:  Marianne Goodman; Tracey Roiff; Allison H Oakes; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 2.  ESCAP Expert Article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice.

Authors:  Peter Fonagy; Mario Speranza; Patrick Luyten; Michael Kaess; Christel Hessels; Martin Bohus
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-08-14       Impact factor: 4.785

3.  Dual-task performance under acute stress in female adolescents with borderline personality disorder.

Authors:  Michael Kaess; Peter Parzer; Julian Koenig; Franz Resch; Romuald Brunner
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-06       Impact factor: 4.785

4.  Impulsivity, aggression and brain structure in high and low lethality suicide attempters with borderline personality disorder.

Authors:  Paul Soloff; Richard White; Vaibhav A Diwadkar
Journal:  Psychiatry Res       Date:  2014-02-18       Impact factor: 3.222

Review 5.  Developmental pathways to borderline personality disorder.

Authors:  Andrew M Chanen; Michael Kaess
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

6.  An exploratory study of the relationship of symptom domains and diagnostic severity to PET scan imaging in borderline personality disorder.

Authors:  S Charles Schulz; Jazmin Camchong; Ann Romine; Amanda Schlesinger; Michael Kuskowski; Jose V Pardo; Kathryn R Cullen; Kelvin O Lim
Journal:  Psychiatry Res       Date:  2013-09-03       Impact factor: 3.222

7.  Structure of genetic and environmental risk factors for symptoms of DSM-IV borderline personality disorder.

Authors:  Ted Reichborn-Kjennerud; Eivind Ystrom; Michael C Neale; Steven H Aggen; Suzanne E Mazzeo; Gun Peggy Knudsen; Kristian Tambs; Nikolai O Czajkowski; Kenneth S Kendler
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

8.  Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United States.

Authors:  Matthew C Lohman; Karen L Whiteman; Frank E Yeomans; Sheila A Cherico; Winifred R Christ
Journal:  Psychiatr Serv       Date:  2016-10-03       Impact factor: 3.084

9.  Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.

Authors:  Jayashri Kulkarni; Natalie Thomas; Abdul-Rahman Hudaib; Emorfia Gavrilidis; Jasmin Grigg; Raelene Tan; Jacinta Cheng; Amelia Arnold; Caroline Gurvich
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

10.  Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls.

Authors:  Vassilis N Panagopoulos; Timothy J Trull; Anne L Glowinski; Michael T Lynskey; Andrew C Heath; Arpana Agrawal; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery; Elliot C Nelson
Journal:  Drug Alcohol Depend       Date:  2012-12-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.